Systemic immune-inflammation index as a novel biomarker for predicting surgical site infection in people living with HIV: a multicenter, retrospective cohort study
The SII may serve as a clinically accessible and cost-effective biomarker for identifying HIV-infected patients at increased risk of SSI. Incorporating preoperative SII assessment could support perioperative risk stratification and management. This novel approach has implications for optimizing patient care for HIV-positive surgical populations.
Authors
- Liqiang Hu
- B Liu
- Changsheng Yang
- Yanguo Wang
- Qiang Zhang
- Xin Li
- Shuo Gong
- Wei Guo
Institutions
- The First Hospital of Changsha (CN)
- Public Health Clinical Center of Chengdu (CN)
- Beijing Ditan Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-02-06
- DOI
- https://doi.org/10.3389/fcimb.2026.1529202
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00